Page 82 - TD-4-1
P. 82

Tumor Discovery                                               Colorectal cancer: miRNA, mRNA, protein insights



            3.3.2. Protein expression of target genes          had a median H-score of 70 (range: 0 – 225), BCL2 had

            In a primary  operable invasive CRC patient cohort,   a median H-score of 125 (range: 0 – 300), KLF4 had a
            we conducted an evaluation to delve deeper into the   median H-score of 90 (range: 0 – 300), and RASA1 had a
            expression of miRNA target genes, including SMAD4,   median H-score of 65 (range: 0 – 200).
            PTEN, TGFBRII, BCL2, KLF4, and RASA1. Staining       As  previously mentioned,  excellent  concordance
            patterns for all markers displayed heterogeneity both   between scorers was observed, as indicated by the single-
            within  and  between  tumor  cores,  ranging  from  weak   measure ICC for SMAD4, PTEN, TGFBRII, BCL2, KLF4,
            to intense staining (Figure 2). Three cores per case were   and RASA1, which ranged from 0.71 to 0.82. Specimens
            stained, and the average scores of these cores were used   were  categorized  into  low  and  high  expression  groups
            for subsequent analysis. The H-score, representing staining   based on mean scores. For instance, 63% of CRC cases
            intensity, was determined for each marker. SMAD4   exhibited low expression of SMAD4, while 37% displayed
            exhibited a median H-score of 85 (range: 0 – 300), PTEN   high expression relative to normal mucosa. Similarly, 83%
            had a median H-score of 95 (range: 0 – 300), TGFBRII   of CRC cases demonstrated low expression of PTEN, with
                                                               17% characterized by high expression. For TGFBRII,
            Table 3. Expression profiles of candidate target genes of   80% of CRC cases were categorized as low expression,
            microRNAs                                          while 20% showed high expression compared to normal
                                                               mucosa. In the case of BCL2, 58% of CRC specimens had
            Gene      Fold of change of   P  P‑value of Bonferroni
                     tumor tissue versus   multiple correction  low expression, whereas 42% exhibited high expression.
                       normal tissue                           For KLF4, 44% of CRC cases exhibited low expression,
            SMAD4         0.98       0.12                      while 56% displayed high expression. Lastly, 75% of CRC
            PTEN          0.97       0.22                      cases  demonstrated  low  expression  of  RASA1,  and  25%
            BCL2          3.72       0.05       0.2            exhibited high expression compared to normal mucosa.
            TGFBRII       0.46       0.001      0.006          Chi-square test was conducted to assess the correlation
                                                               between mRNA and protein level of the markers used in
            KLF4          1.18       0.8                       this study. Results demonstrated a significant correlation
            RASA1         0.66       0.002      0.01           between mRNA and protein levels of SMAD4 (r = 0.466,


            A               E                 I             M                 Q               U






            B               F                J               N                R               V






            C               G                K               O                S               W






            D               H                L               P               T                X







            Figure  2.  Representative  photomicrographs  of  various  staining  intensity  of  markers  in  colorectal tissue:  (A-D)  SMAD4,  (E-H)  PTEN,  (I-L)  BCL2,
            (M-P) TGFBRII, (Q-T) KLF4, and (U-X) RASA1. Photomicrographs were viewed at ×100 magnification, whereas images at the inset boxes were at ×200
            magnification; scale bar = 100 µm.


            Volume 4 Issue 1 (2025)                         74                                doi: 10.36922/td.4631
   77   78   79   80   81   82   83   84   85   86   87